Terumo CDI System 500 Monitor Recalled for H/Sat Module Self-Test Failure
Terumo is recalling 128 CDI System 500 monitors because a subset of devices fail the automated H/Sat Color Chip Test. This failure disables the H/Sat module but does not cause device inaccuracy.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The source explicitly states that the issue 'will not result in device inaccuracy,' only disabling a specific module. This aligns with the rubric for moderate severity, representing a functional limitation or precautionary recall without reported harm or inaccuracy.
Plain-English summary
Terumo Cardiovascular Systems Corporation is recalling 128 units of the CDI System 500 monitor, specifically the 500AHCT and 500AVHCT models. These devices provide continuous, on-line monitoring of extracorporeal blood parameters, including oxygen and carbon dioxide partial pressure, pH, potassium, oxygen saturation, hematocrit, hemoglobin, and temperature.
The recall is due to a hybrid intensity shift observed in a subset of the H/Sat population. This shift causes the devices to fail the H/Sat Color Chip Test, which is an automated self-test performed when the device is powered on. According to the source text, this failure disables the H/Sat module but does not result in device inaccuracy for the other monitored parameters.
The affected units were distributed worldwide, including nationwide in the United States and to regions in the Middle East, Latin America, Europe, Japan, Canada, and Mexico. Users should check their device serial numbers against the list provided in the official recall notice to determine if their unit is affected.
The recalled product
- Product
- Monitor with one Blood Parameter Module and one HSat Probe; 500AHCT Monitor with two Blood Parameter modules and one HSat Probe; 500AVHCT Product Usage: The CDI System 500 provides continuous, on-line monitoring of the extracorporeal partial pressure of oxygen and carbon dio
- Manufacturer
- Terumo Cardiovascular Systems Corporation
- Category
- Medical Device — Patient Monitor
- Affected units
- 128
Distribution
Part of a larger recall action
This product is one of 2 recalled by Terumo Cardiovascular Systems Corporation under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Terumo Cardiovascular Systems Corporation
See all →- HighCDI OneView System BPM Probe temperature sensor measurement inaccuracy
FDA (Devices) · 2025-07-02
- HighTerumo CDI OneView Monitor Probe May Fail to Display Oxygen Saturation Data
FDA (Devices) · 2025-04-09
- HighCardiovascular Procedure Kits Recalled for Pressure Relief Valve Defect
FDA (Devices) · 2024-04-10
- HighCAPIOX FX25 Oxygenator Recalled for Potential Leaks from Improper Bonding
FDA (Devices) · 2023-04-12
- HighTerumo Recalls CAPIOX NX19 Oxygenator Due to Improper Bonding
FDA (Devices) · 2023-04-12
Same hazard · self test failure
See all →- HighZOLL Powerheart G5 AED May Fail Self-Test in Extreme Conditions
FDA (Devices) · 2025-03-19
- HighZOLL Powerheart G5 AED may fail self-test in extreme environments
FDA (Devices) · 2025-03-19
- HighZOLL Powerheart G5 AED may fail self-test in extreme temperatures or humidity
FDA (Devices) · 2025-03-19
- HighZOLL Powerheart G5 AED May Fail Self-Test in Extreme Environmental Conditions
FDA (Devices) · 2025-03-19
- HighZOLL Powerheart G5 AED Self-Test May Fail Under Extreme Environmental Conditions
FDA (Devices) · 2025-03-19